Thailand's Food and Drug Administration (FDA) has issued a warning for people visiting entertainment venues following reports of suspected GHB exposure. A person was hospitalized after experiencing seizures, believed to be caused by the substance. The exact nature of the drug is still under investigation, but the risks associated with drink-spiking have prompted an urgent advisory.
Get today's headlines by email 
The FDA's alert comes after concerns about substances like GHB, alprazolam, ketamine, and flunitrazepam being secretly added to drinks. These drugs can rapidly impact the nervous system, causing symptoms such as dizziness, confusion, and breathing difficulties within minutes. The warning highlights the growing issue of illegal drug use at social venues where such psychotropic substances are circulated.
To ensure safety, the FDA advises revellers to keep an eye on their drinks, avoid using previous glasses, and only open or mix beverages themselves. It’s recommended to go out in groups and stay alert for any unusual symptoms in friends. In case of adverse reactions, immediate assistance from friends or venue staff is crucial, with the person being taken swiftly to a hospital.
Looking forward, the FDA aims to increase monitoring of illegal drug sales, particularly online, and encourages the public to report suspicious activities to their hotline. The situation underscores the ongoing challenge of controlling illegal substances in social settings and the need for collective vigilance.
Join the discussion? 
Already a member? 
Adapted by ASEAN Now · The Nation · 15 Apr 2026
-
1
Recommended Comments
Create an account or sign in to comment